Reference
Gottlieb S. Statement from FDA Commissioner Scott Gottlieb, M.D., on 2019 efforts to advance the development of complex generics to improve patient access to medicines. Internet Document : 30 Jan 2019. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm630160.htm
Rights and permissions
About this article
Cite this article
New steps in US to promote development of complex generics. PharmacoEcon Outcomes News 821, 4 (2019). https://doi.org/10.1007/s40274-019-5621-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5621-3